# The Pharmacological Effects of Using Cabozantinib With a Light Breakfast

> **NCT05263245** · PHASE2 · COMPLETED · sponsor: **dr. Tom van der Hulle** · enrollment: 12 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **OTHER:** Light breakfast

## Key facts

- **NCT ID:** NCT05263245
- **Lead sponsor:** dr. Tom van der Hulle
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-25
- **Primary completion:** 2025-03-11
- **Final completion:** 2025-03-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05263245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05263245, "The Pharmacological Effects of Using Cabozantinib With a Light Breakfast". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05263245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*